Factory To Begin ARV Production By August 2012

BMI View: Mozambique's pharmaceutical market is characterised by a poor regulatory framework, an abundance of counterfeit medicines, low levels of government spending, a very small private healthcare sector and a lack of demand for innovative drugs, which is exacerbated by weak intellectual property protection. But Mozambique has a fast-growing economy thanks to its natural resources and agricultural industry. BMI believes while short-term demand will be limited to low-value generic drugs and vaccines, the creation of a national regulatory body will help to encourage investment by multinationals. The creation of domestic production facilities will also attract other

To read the full article, please choose one of the following options: